| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $536K | -0.6% |
| Gross Profit | -$97.8M | -17.1% |
| R&D Expense | $16.6M | -34.2% |
| SG&A Expense | $55.7M | +29.1% |
| Operating Income | -$331.1M | -121.1% |
| Pre-tax Income | -$397.0M | -11.5% |
| Income Tax | $63K | +123.6% |
| Net Income | -$390.7M | -9.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.9M | +388.9% |
| Accounts Receivable | $257K | — |
| Inventory | $3.3M | -88.1% |
| Current Assets | $68.5M | -4.7% |
| Total Assets | $277.9M | -34.7% |
| Current Liabilities | $148.2M | -23.1% |
| Total Liabilities | $270.1M | -13.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$107.6M | -53.3% |
| Capital Expenditures | $7.6M | +0.8% |
| Investing Cash Flow | -$23.5M | -217.8% |
| Financing Cash Flow | $161.4M | +99.9% |
| Free Cash Flow | -$115.2M | -48.2% |
| -$27.3M |
| -123.8% |